← All diseases
Cancer
Lung cancer (small cell)
Do you want to receive a message when there is new research about Small Cell Lung Cancer (SCLC)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you see one sentence explaining what was studied — and you'll be notified as soon as there is new research about Small cell lung cancer. View what Premium costs.
Publications and studies (3320)
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Onychopathy Following Durvalumab Treatment for Extensive-Stage Small-Cell Lung Cancer: A Case Report. (2023/09/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Successful treatment of immune-related lichenoid dermatitis by Weiling decoction in a patient with non-small cell lung cancer: A case report and review of literature. (2023/09/01) ♡
- Scoparone induces both apoptosis and ferroptosis via multiple mechanisms in non-small-cell lung cancer cells. (2023/09/01) ♡
- Ethanol Extract of Citrus grandis' Tomentosa 'Exercises Anticancer Effects by Targeting SKP2/p27 Pathway in Non-Small Cell Lung Cancer. (2023/09/01) ♡
- Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancer. (2023/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Anamorelin in Japanese patients with cancer cachexia: an update. (2023/09/01) ♡
- Methylseleninic acid overcomes gefitinib resistance through asparagine-with-TOPK signaling axis in non-small cell lung cancer cells. (2023/09/01) ♡
- Correlations between class I glucose transporter expression patterns and clinical outcomes in non-small cell lung cancer. (2023/09/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Pembrolizumab as first-line treatment for advanced NSCLC in older adults: A phase II clinical trial evaluating geriatric and quality-of-life outcomes. (2023/09/01) ♡
- Predictive Value of Modified Glasgow Prognostic Score and Persistent Inflammation among Patients with Non-Small Cell Lung Cancer Treated with Durvalumab Consolidation after Chemoradiotherapy: A Multicenter Retrospective Study. (2023/09/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Naples prognostic score as a predictor of outcomes in lung cancer: a systematic review and meta-analysis. (2023/09/01) ♡
- Risk factors influencing chemotherapy compliance and survival of elderly patients with non-small cell lung cancer. (2023/09/01) ♡
- Incidence and predictors of infections in patients with advanced non-small cell lung cancer treated with checkpoint inhibitor immunotherapies: A monocentric retrospective cohort study. (2023/09/01) ♡
- Obesity and risk for respiratory diseases: a Mendelian randomization study. (2023/08/29) ♡
- The value of CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in patients with non-small cell lung cancer. (2023/08/23) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Physical exercise reverses immuno-cold tumor microenvironment via inhibiting SQLE in non-small cell lung cancer. (2023/08/18) ♡
- A novel quinoline derivative, DFIQ, sensitizes NSCLC cells to ferroptosis by promoting oxidative stress accompanied by autophagic dysfunction and mitochondrial damage. (2023/08/16) ♡
- Maintenance anlotinib improves the survival prognosis of extensive-stage small cell lung cancer: a single-arm, prospective, phase II study. (2023/08/15) ♡
- DNMT3A governs tyrosine kinase inhibitors responses through IAPs and in a cell senescence-dependent manner in non-small cell lung cancer. (2023/08/15) ♡
- The D-trace loss cluster for differential network analysis. (2023/08/14) ♡
- Role of ALK Inhibitors in Anaplastic Large Cell Lymphoma Experience from an Indian Center. (2023/08/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of proteasomes in tumorigenesis. (2023/08/06) ♡
- Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma (2023/08/05) ♡
- JK5G postbiotics attenuate immune-related adverse events in NSCLC patients by regulating gut microbiota: a randomized controlled trial in China. (2023/08/04) ♡
- Endoscopic management of upper tract urothelial cancer in a highly endemic area: A Taiwan nationwide collaborative study. (2023/08/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. A meta-analysis of the Zilongjin tablets for non-small cell lung cancer and its network pharmacology of action against NSCLC and COVID-19. (2023/08/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. [Prediction and analysis of Q-markers of Elephantopus scaber based on its UPLC fingerprint, content determination of components, and in vitro an anti-tumor activity]. (2023/08/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Adenosine monophosphate-activated protein kinase is elevated in human cachectic muscle and prevents cancer-induced metabolic dysfunction in mice. (2023/08/01) ♡
- Is the Preoperative Prognostic Nutritional Index a Useful Marker for the Decision to Perform Limited Resection in High-risk Patients With Stage I Non-small Cell Lung Cancer? (2023/08/01) ♡
- Treatment outcome of metastasis to the pituitary gland: a case series of 21 patients with pathological diagnosis. (2023/08/01) ♡
- Coexistence of pulmonary tuberculosis and small cell lung carcinoma: A significant problem in tuberculosis endemic country? (2023/08/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Identification of prognostic nutritional index as a reliable prognostic indicator for advanced lung cancer patients receiving immune checkpoint inhibitors. (2023/07/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Molecular testing in non-small cell lung cancer: A consensus recommendation. (2023/07/28) ♡
- Common nutritional/inflammatory indicators are not effective tools in predicting the overall survival of patients with small cell lung cancer undergoing first-line chemotherapy. (2023/07/27) ♡
- [A Prognostic Model of Elderly Patients with Non-small Cell Lung Cancer Based on Geriatric Nutritional Risk Index]. (2023/07/20) ♡
- Multimodal prehabilitation in patients with non-small cell lung cancer undergoing anatomical resection: protocol of a non-randomised feasibility study. (2023/07/19) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Predictive value of the prognostic nutritional index in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis. (2023/07/19) ♡
- Feasibility and long-term outcomes of post-chemotherapy-based consolidation radiotherapy in extensive stage small-cell lung cancer. (2023/07/19) ♡
- Clinical application of common inflammatory and nutritional indicators before treatment in prognosis evaluation of non-small cell lung cancer: a retrospective real-world study. (2023/07/13) ♡
- The development and validation of a nomogram for predicting brain metastases after chemotherapy and radiotherapy in male small cell lung cancer patients with stage III. (2023/07/11) ♡
- Single-cell RNA sequencing reveals enhanced antitumor immunity after combined application of PD-1 inhibitor and Shenmai injection in non-small cell lung cancer. (2023/07/10) ♡
- Prognostic roles of hematological indicators for the efficacy and prognosis of immune checkpoint inhibitors in patients with advanced tumors: a retrospective cohort study. (2023/07/07) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Sacubitril/Valsartan Ameliorates Crizotinib-Induced Cardiotoxicity in Mice. (2023/07/03) ♡
- The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors. (2023/07/01) ♡
- Efficacy and safety of EGFR‑TKis plus Shenqi Fuzheng injection for non-small cell lung cancer patients with EGFR-sensitive mutations. (2023/07/01) ♡
- Identification of the active compounds in the Yi-Fei-San-Jie formula using a comprehensive strategy based on cell extraction/UPLC-MS/MS, network pharmacology, and molecular biology techniques. (2023/07/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. [Blaps rynchopetera affects proliferation, migration, and invasion of non-small cell lung cancer: a study based on network pharmacology and in vivo and in vitro experiments]. (2023/07/01) ♡
- Impact of the pretreatment prognostic nutritional index on the survival after first-line immunotherapy in non-small-cell lung cancer patients. (2023/07/01) ♡
- Lidocaine induces epithelial‑mesenchymal transition and aggravates cancer behaviors in non‑small cell lung cancer A549 cells. (2023/06/27) ♡
- Role of endogenous and exogenous antioxidants in risk of six cancers: evidence from the Mendelian randomization study. (2023/06/27) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.